A fresh study by researchers at the Karolinska Institute in Stockholm.

Nils Dr and Wilking. Bengt Jonsson, director of the Center for Wellness Economics at the Stockholm School of Economics, surveyed 19 European countries in addition to Australia, Canada, New Zealand, Japan, South Africa and the U.S. Top of the league for their malignancy treatment were Austria, France, Switzerland and the U.S. Where doctors insist upon using new cancer medications. Related StoriesNew RNA check of blood platelets may be used to identify area of cancerNew antenna-like gadget makes breast cancer medical procedures easier for surgeonsMeat-rich diet plan may increase kidney cancer riskFrance also experienced the highest five-year survival rate for all cancers , where 71 % of women and 53 % of men survived each whole year from diseases linked to cancer.Global Investment, Inc. This funding shall allow for expansion of existing functions, and the clinical development of potentially first-in-course biopharmaceuticals targeting diseases of the central anxious program , which are constructed to penetrate the blood-brain barrier . This is the first-time such a diverse group from the pharmaceutical industry has come together to financing technology in the blood-brain barrier. I am extremely delighted at the trust our investors have placed in us, stated William M.